Saturday , December 16 2017
Home / Managing Editor, Diabetes in Control (page 34)

Managing Editor, Diabetes in Control

Managing Editor, Diabetes in Control

September 29, 2015

Reminder – on October 1st, 2015, we will be relaunching DiabetesInControl.com. The refreshed site will feature a clean, new look and feel, with enhanced navigation to make it even easier to find all our great content. We’ve also decided to make some of our most popular content, including our “Tools …

Read More »

Can Smaller Forks Help Diabetes Patients?

Patient, female, 54 years of age, type 2 diabetes and obesity, told me she thought her weight and subsequent type 2 diabetes related to overeating, especially large portions. She is being seen by a behavior therapist for her eating disorder. I started her on a GLP-1. Even at starting dose, she reported feeling more satiated, but still overeating. The dose was increased...

Read More »

Letter From the Editor, Sept. 19, 2015

It seems like every time we get good news about a diabetes drug, the bad has to surface. This week, Lilly and BI announced some great heart results with their drug Jardiance, while the FDA tightened up its warning on Invokana and fracture risk. The same thing happens in other …

Read More »

HealthSuite Digital Platform

Product of the Week - connected digital health prototype enables people living with diabetes and their health care providers to make more confident care decisions, while managing the complexity of diabetes self-care.

Read More »

Test Your Knowledge Question #799

Test Your Knowledge

A 62-year old Asian-American female arrives at your office for a new patient appointment. Her current medications are metformin, pioglitazone, enalapril, lovastatin, alendronate, calcium supplements and vitamin D. Her A1C is on target at 6.9%, however you decide to replace her pioglitazone with a different antihyperglycemic medication. Why would you make this decision? Follow link to answer!

Read More »